Raw Data Fig 4. 10 healthy plasma ratio and count,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,
"Using the flow cytometric method described above, each m/lEVs characterized was counted, and the ratio of the total m/lEVs excluding nonspecific binding is shown.",,,,,,,,,,,,,,,,,
Here is the result of 10 healthy people about the m/lEVs derived from each blood cell .,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,
m/lEVs ratio( % whole),,,,,,,,,,,,,,,,,
,,An5,healthy plasma 1,healthy plasma 2,healthy plasma 3,healthy plasma 4,healthy plasma 5,healthy plasma 6,healthy plasma 7,healthy plasma 8,healthy plasma 9,healthy plasma 10,,Average,SD,min,max
Erythrocyte,An5+ CD45- CD235a+ CD59+,+,12%,15%,16%,9.70%,13%,6.00%,8.30%,2.80%,7.60%,11%,,10%,4.20%,2.80%,16%
,An5- CD45- CD235a+ CD59+,-,0.01%,0.06%,0.03%,0.15%,0.06%,0.03%,0.23%,0.00%,0.84%,0.21%,,0.16%,0.25%,0.00%,0.84%
Platelet,An5+ CD5- CD45- CD61+ CD41+,+,29%,19%,10%,26%,21%,19%,12%,4.60%,30%,17%,,19%,8.20%,4.60%,30%
,An5- CD5- CD45- CD61+ CD41+,-,14%,2.60%,23%,8.80%,8.50%,22%,13%,5.20%,30%,32%,,16%,10%,2.60%,32%
Macrophage,An5+ CD235a- CD45+ CD15+,+,0.94%,0.13%,1.30%,1.00%,0.53%,0.16%,0.09%,0.02%,0.02%,0.12%,,0.43%,0.49%,0.02%,1.30%
,An5- CD235a- CD45+ CD15+,-,0.31%,0.01%,0.21%,0.06%,0.03%,0.06%,0.01%,0.00%,0.01%,0.00%,,0.07%,0.10%,0.00%,0.31%
T and Bcell ,An5+ CD235a- CD45+ CD5+,+,0.14%,0.16%,0.77%,0.11%,0.09%,0.45%,0.01%,0.01%,0.02%,0.11%,,0.19%,0.24%,0.01%,0.77%
,An5- CD235a- CD45+ CD5+,-,0.79%,0.19%,0.57%,1.40%,0.70%,0.45%,0.23%,0.05%,0.27%,0.36%,,0.50%,0.40%,0.05%,1.40%
Endothelial,An5+ CD105+ CD146+,+,0.10%,0.09%,0.20%,0.12%,0.07%,0.09%,0.02%,0.04%,0.02%,0.04%,,0.08%,0.05%,0.02%,0.20%
,An5- CD105+ CD146+,-,0.04%,0.04%,0.02%,0.09%,0.03%,0.03%,0.01%,0.01%,0.01%,0.02%,,0.03%,0.03%,0.01%,0.09%
,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,
m/lEVs count,,An5,healthy plasma 1,healthy plasma 2,healthy plasma 3,healthy plasma 4,healthy plasma 5,healthy plasma 6,healthy plasma 7,healthy plasma 8,healthy plasma 9,healthy plasma 10,,,,,
Erythrocyte,"whole count
 (Non-specific binding to mIgG was excluded )",,9479,9572,9500,9515,9417,9343,7996,9527,8799,9507,,,,,
,An5+ CD45- CD235a+ CD59+,+,1121,1478,1541,922,1190,559,660,267,672,1071,,,,,
,An5- CD45- CD235a+ CD59+,-,1,6,3,14,6,3,18,0,74,20,,,,,
Platelet,"whole count
 (Non-specific binding to mIgG was excluded )",,9473,9607,9589,9309,9399,9459,7989,9541,8820,9497,,,,,
,An5+ CD5- CD45- CD61+ CD41+,+,2708,1851,938,2380,1958,1801,993,437,2646,1624,,,,,
,An5- CD5- CD45- CD61+ CD41+,-,1305,254,2189,823,800,2101,1036,495,2621,3022,,,,,
Macrophage,"whole count
 (Non-specific binding to mIgG was excluded )",,9479,9572,9648,9453,9367,9477,7753,9530,8585,9505,,,,,
,An5+ CD235a- CD45+ CD15+,+,89,12,129,94,50,15,7,2,2,11,,,,,
,An5- CD235a- CD45+ CD15+,-,29,1,20,6,3,6,1,0,1,0,,,,,
T and Bcell ,"whole count
 (Non-specific binding to mIgG was excluded )",,9479,9572,9648,9501,9367,9477,7753,9530,8585,9505,,,,,
,An5+ CD235a- CD45+ CD5+,+,13,15,74,10,8,43,1,1,2,10,,,,,
,An5- CD235a- CD45+ CD5+,-,75,18,55,134,66,43,18,5,23,34,,,,,
Endothelial,"whole count
 (Non-specific binding to mIgG was excluded )",,9578,9607,9602,9536,9447,9551,8626,9483,8831,9563,,,,,
,An5+ CD105+ CD146+,+,10,9,19,11,7,9,2,4,2,4,,,,,
,An5- CD105+ CD146+,-,4,4,2,9,3,3,1,1,1,2,,,,,